University of California San Diego Nov 18 2025 Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease. Their approach employs an antibody-drug conjugate - a delivery system that uses an antibody to identify cancer cells and deliver a highly potent chemotherapy directly into those cells without harming surrounding